Showing posts with label COVID-19 Lifestyle. Show all posts
Showing posts with label COVID-19 Lifestyle. Show all posts

9/04/2026

Advances in Diabetes Care: Impact of Onset Age, Lifestyle Factors, and Novel Clinical Insights

Journal of Diabetes Investigation: Volume 13, Issue 6 Summary

This issue of the Journal of Diabetes Investigation brings to light critical clinical and lifestyle factors that directly influence the daily management and long-term outcomes of individuals living with diabetes. The selected studies underscore several key themes in modern diabetes care:

  • The Timing of Diagnosis: How early-onset type 2 diabetes significantly elevates the risk of microvascular complications, highlighting the critical need for early preventative care.
  • Prescribing Trends & Safety: Analyzing shifts in medication selection, specifically the rise in sodium-glucose cotransporter 2 inhibitor (SGLT2i) prescriptions, and the vital need for medical guidelines to ensure safe clinical practice in patients with kidney dysfunction.
  • Environmental and Lifestyle Influences: Uncovering the surprising ways remote working (telework) and pet ownership affected glycemic control during the COVID-19 pandemic.
  • Dietary Protective Factors: Exploring the relationship between regular coffee consumption and slower kidney function decline.
  • Precision Injection Care: Utilizing advanced imaging technology (shear wave elastography) to quantitatively evaluate tissue damage from repeated insulin injections.

For patients, families, and healthcare providers, these findings offer practical insights into personalizing diabetes management, improving lifestyle habits, and optimizing clinical safety.

Disclaimer The information presented in this article is provided for informational purposes only. The blog and its author assume no responsibility for the accuracy, safety, completeness, or reliability of the information. Any actions or decisions based on the information in this article are the sole responsibility of the reader.

This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Age of Onset & Complications

Relationship between onset age of type 2 diabetes mellitus and vascular complications based on propensity score matching analysis

Authors: Lingning Huang, Peiwen Wu, Yongze Zhang, Yanxian Lin, Ximei Shen, Fengying Zhao, Sunjie Yan

Research Objective: To investigate how the age at which a person is diagnosed with type 2 diabetes relates to their risk of developing vascular complications later in life.

Methods: A retrospective review of 3,568 patients with type 2 diabetes in China was conducted. Patients were grouped into early-onset (before 40 or 60 years) and late-onset (after 40 or 60 years). To ensure a fair comparison, a statistical technique called propensity score matching (PSM) was used to balance baseline characteristics between the groups.

Main Findings: Before adjusting for other factors, patients with early-onset diabetes had a higher risk for both macrovascular (large blood vessels) and microvascular (small blood vessels) complications. After matching, there was no significant difference in the risk of macrovascular complications between early- and late-onset groups. However, the risk of microvascular complications remained significantly higher in the early-onset groups. Specifically, those diagnosed before age 40 had a 2.9-fold increased risk of diabetic retinopathy (eye damage), a 1.9-fold risk of chronic kidney disease, and a 1.6-fold risk of peripheral neuropathy (nerve damage) compared to those diagnosed later.

Clinical Significance: An earlier diagnosis of type 2 diabetes carries a significantly higher burden of microvascular damage, likely due to a longer lifetime exposure to high blood sugar levels. This highlights the crucial need for early, proactive monitoring and intervention.

Key Points for Patients: Being diagnosed with type 2 diabetes at a younger age means your body is exposed to blood sugar fluctuations for a longer period. This makes routine eye, kidney, and nerve screenings particularly important. However, remember that proactive management can protect your blood vessels at any age.

Clinical Practice & Prescription Trends

Current status of diabetes treatment in Miyazaki Prefecture, Japan: Results of a questionnaire survey conducted in 2016 and 2020

Authors: Yudai Uehira, Hiroaki Ueno, Emi Ebihara, Taisuke Uchida, Hiroki Nabekura, Hideyuki Sakoda, Tadato Yonekawa, Hideki Yamaguchi, Masamitsu Nakazato

Research Objective: To assess prescribing habits and glycemic control targets among diabetologists and non-diabetologists in Miyazaki Prefecture, Japan, and how these choices changed between 2016 and 2020.

Methods: Unsigned surveys were distributed to local physicians in July 2016 and March 2020. The researchers compared the choices of blood-sugar-lowering drugs for various patient scenarios between specialists and non-specialists.

Main Findings: Most diabetologists preferred biguanides as a first-line treatment for obese patients. Additionally, the prescription rate of sodium-glucose cotransporter 2 inhibitors (SGLT2i) rose significantly by 2020 as clinical evidence supporting their benefits grew. However, the survey also revealed that a small number of physicians (both specialists and non-specialists) incorrectly selected biguanides or SGLT2i for patients with severe kidney dysfunction, where these drugs are generally not recommended.

Clinical Significance: While doctors are successfully integrating new, highly effective therapies like SGLT2i into clinical practice, there is an ongoing need for medical education regarding the safety restrictions of these medications in patients with reduced kidney function.

Key Points for Patients: Medical guidelines change as new evidence emerges. It is important to regularly discuss your medication list with your healthcare provider to ensure that your treatments remain safe, especially if your kidney function changes over time.

Lifestyle & Environment

Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study

Authors: Aiko Terakawa, Ryotaro Bouchi, Noriko Kodani, Tomoko Hisatake, Takehiro Sugiyama, Michihiro Matsumoto, Noriko Ihana-Sugiyama, Mitsuru Ohsugi, Kohjiro Ueki, Hiroshi Kajio

Research Objective: To examine how lifestyle, living, and working adjustments during the COVID-19 state of emergency in Japan influenced blood sugar levels (HbA1c) and to determine if medical treatments were adjusted appropriately.

Methods: This retrospective study included 321 participants who completed questionnaires about their home and work environment during the pandemic. Changes in HbA1c levels were compared between 2019 (pre-pandemic) and 2020 (during the pandemic).

Main Findings: Overall, average HbA1c levels did not significantly worsen during the pandemic (7.13% in 2019 vs. 7.18% in 2020). However, specific environmental factors showed clear associations: working from home (teleworking) was associated with an increase in HbA1c, whereas living with a dog was linked to a decrease in HbA1c. Treatment intensification rates remained steady between the two periods.

Clinical Significance: Minor, everyday variables—such as the decreased physical activity from working at home or the mandatory physical routine of walking a dog—can play a measurable role in blood sugar control during periods of societal disruption.

Key Points for Patients: Environmental shifts can easily disrupt your diabetes management routine. If you telework, you may need to intentionally schedule movement breaks throughout your day. Conversely, positive habits like walking a pet can naturally help support blood sugar management.

Dietary Habits & Kidney Protection

Relationship of coffee consumption with a decline in kidney function among patients with type 2 diabetes: The Fukuoka Diabetes Registry

Authors: Yuji Komorita, Toshiaki Ohkuma, Masanori Iwase, Hiroki Fujii, Hitoshi Ide, Yutaro Oku, Taiki Higashi, Ayaka Oshiro, Wakako Sakamoto, Masahito Yoshinari, Udai Nakamura, Takanari Kitazono

Research Objective: To investigate if coffee consumption is linked to the rate of decline in kidney function among people living with type 2 diabetes.

Methods: This prospective study observed 3,805 patients with type 2 diabetes from the Fukuoka Diabetes Registry who had a healthy baseline estimated glomerular filtration rate (eGFR ≥ 60 mL/min/1.73 m²). Changes in their kidney function were tracked over time.

Main Findings: During the follow-up period, 840 participants experienced a decline in kidney function (defined as eGFR dropping below 60 mL/min/1.73 m²). The analysis revealed that coffee consumption was significantly associated with a lower risk of this decline.

Clinical Significance: This is the first prospective registry study to show that regular coffee consumption may have a protective effect against kidney function decline specifically in people with diabetes.

Key Points for Patients: If you enjoy coffee, this habit might be offering a protective benefit for your kidneys. However, it is always wise to discuss your daily caffeine intake and diet with your healthcare team to ensure it fits with your personal health goals.

Advanced Diagnostics & Injection Care

Quantitative evaluation of insulin-induced abdominal subcutaneous dystrophic tissue using shear wave elastography

Authors: Genki Sato, Hiroshi Uchino, Yosuke Shimizu, Junko Tatebe, Toshisuke Morita, Takahisa Hirose

Research Objective: To determine if a high-tech ultrasound technique called shear wave elastography (SWE) can accurately measure and map hardened, damaged tissue caused by repeated insulin injections.

Methods: Researchers evaluated 7 patients with type 2 diabetes who had used multiple daily insulin injections for many years. SWE was used to measure tissue stiffness (shear wave velocity) in damaged areas (dystrophic tissue) versus healthy skin. In two patients, 3D mapping was performed to measure the exact volume of damaged tissue. Additionally, a subcutaneous insulin tolerance test was administered to compare absorption rates between damaged and normal tissues.

Main Findings: Damaged injection-site tissue was significantly stiffer than normal subcutaneous tissue. The damaged areas accounted for up to 5.21% of the abdominal fat volume in one of the mapped patients. Crucially, the absorption of fast-acting insulin (aspart) was notably lower in the damaged areas compared to normal tissue.

Clinical Significance: Repeated injections in the same area lead to lipodystrophy (stiff, damaged tissue), which impairs insulin absorption and can cause unexpected blood sugar spikes or drops. SWE represents a promising non-invasive tool to help identify and manage this issue.

Key Points for Patients: Regularly rotating your injection sites is essential. Injecting into hardened skin areas means your body will not absorb insulin efficiently, making your blood sugar harder to control. If you suspect you have lumps or hardened areas on your abdomen, ask your clinic to check them.

9/03/2026

Advancing Diabetes Care: Hospital Digital Dashboards, Nerve Regeneration, and Early Support Strategies

Journal of Diabetes Investigation: Vol. 12, Issue 9 Review

This month's issue highlights powerful clinical breakthroughs and practical insights across the spectrum of diabetes care. Key themes include how digital health and remote monitoring dashboards can drastically improve hospital stay durations, the direct nerve-healing benefits of intensive blood sugar control, and how lifestyle containment measures during the pandemic affected younger and older populations in different ways.

Additionally, researchers explore critical safety warnings regarding SGLT2 inhibitor use in Type 1 diabetes, the profound value of immediate nutritional and eye exams in preventing treatment dropouts, and the underlying commonalities between Type 1 and Type 2 diabetes cell failures.

Disclaimer The information presented in this article is provided for informational purposes only. The blog and its author assume no responsibility for the accuracy, safety, completeness, or reliability of the information. Any actions or decisions based on the information in this article are the sole responsibility of the reader.

This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Digital Health & Remote Monitoring

Electronic Dashboard-Based Remote Glycemic Management Program Reduces Length of Stay and Readmission Rate Among Hospitalized Adults

Authors: Yi‐Jing Sheen, Chien‐Chung Huang, Shih‐Che Huang, Ching‐Heng Lin, I‐Te Lee, Wayne H‐H Sheu

Research Objective: To evaluate the clinical impact of a 4-year, hospital-wide remote blood glucose monitoring dashboard on the length of hospital stay (LOS) and 30-day readmission rates for hospitalized adult patients.

Methods: A retrospective study evaluating 106,528 hospitalized patients who received glucose monitoring. Patients were divided into four glycemic categories ranging from high variability, hypoglycemia, hyperglycemia, to relatively stable control. Researchers tracked change trends using joinpoint regression from 2016 to 2019.

Main Findings: Implementing the dashboard led to a significant shift from poor blood sugar control categories to the stable group. There was an 11.4% reduction in length of hospital stay and a drop in 30-day readmissions (from 29.9% to 29.3%), primarily driven by patients achieving stable control.

Clinical Significance: Utilizing structured digital remote management tools across an entire hospital system optimizes patient recovery times, reduces the risk of readmission, and decreases associated medical costs.

Key Points for Patients: When hospitals use advanced digital dashboards to closely monitor and manage blood sugar levels remotely, patients recover faster, spend less time in hospital beds, and are less likely to be readmitted shortly after discharge.

COVID-19 & Lifestyle Impacts

Lifestyle Changes as a Result of COVID-19 Containment Measures: Bodyweight and Glycemic Control in Patients with Diabetes in the Japanese Declaration of a State of Emergency

Authors: Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamasaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino

Research Objective: To clarify how lifestyle changes during the Japanese COVID-19 state of emergency affected metabolic status, body weight, and HbA1c levels in patients with diabetes.

Methods: A single-center, cross-sectional observational study using a self-reported questionnaire from 463 patients to record active habits before and after containment measures. The analysis was stratified by age (under 65 versus 65 and older).

Main Findings: Shifts in HbA1c levels directly correlated with body weight changes. For patients under 65, increased snacking significantly elevated body weight and HbA1c. Conversely, for patients aged 65 and older, weight gain was primarily associated with reduced walking activity.

Clinical Significance: Public health containment measures impact diabetes management in age-dependent ways, requiring customized guidance (snacking management for younger adults and mobility-maintenance programs for seniors).

Key Points for Patients: Major disruptions to daily routines, like pandemic lockdowns, affect our health differently depending on our age. Younger individuals may need to watch mid-day snacking, whereas older adults should focus on maintaining daily physical activities like walking.

Pathophysiology & Disease Mechanisms

β-Cell Failure in Diabetes: Common Susceptibility and Mechanisms Shared Between Type 1 and Type 2 Diabetes

Authors: Hiroshi Ikegami, Naru Babaya, Shinsuke Noso

Research Objective: To review shared genetic susceptibilities and common biological pathways of pancreatic beta-cell (insulin-producing cell) failure across both Type 1 and Type 2 diabetes subtypes.

Methods: A comprehensive review of recent literature examining molecular mechanisms and genetic markers involved in diabetic beta-cell degradation.

Main Findings: Despite having distinct starting causes and immune system profiles, Type 1 and Type 2 diabetes share key downstream genetic susceptibilities and molecular pathways that lead to cellular stress and eventual beta-cell death.

Clinical Significance: Pinpointing these universal destructive mechanisms helps researchers design overarching therapies capable of preserving insulin secretion regardless of the patient's specific diabetes subtype.

Key Points for Patients: Although Type 1 and Type 2 diabetes are different conditions, they share a "common enemy" in how their insulin-producing cells fail. Scientists are using these shared biological pathways to research new treatments that could help individuals with either type of diabetes.

Animal Physiology Study

Glucokinase is Required for High-Starch Diet-Induced β-Cell Mass Expansion in Mice

Authors: Kazuhisa Tsuchida, Akinobu Nakamura, Hideaki Miyoshi, Kelaier Yang, Yuki Yamauchi, Shinichiro Kawata, Kazuno Omori, Kiyohiko Takahashi, Naoyuki Kitao, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, Yusuke Seino, Yasuo Terauchi, Tatsuya Atsumi

Research Objective: To determine if glucokinase—a key enzyme in glucose metabolism—is necessary for the pancreas to expand its beta-cell mass when exposed to a high-starch diet (HSTD).

Methods: Eight-week-old male wild-type and glucokinase-heterozygous (Gck+/-) mice were fed either a high-starch diet or a control diet, followed by physical and microscopic evaluations of pancreatic tissues.

Main Findings: A high-starch diet naturally triggers an expansion of beta-cell mass and increased insulin secretion in normal wild-type mice, but this crucial protective adaptation is disrupted or impaired in mice lacking a fully functional glucokinase enzyme.

Clinical Significance: This study highlights the essential role of glucokinase in helping the pancreas adapt to carbohydrate-heavy diets, further elucidating how dietary elements interact with genetics.

Key Points for Patients: Laboratory studies show that our bodies rely on specific enzymes (like glucokinase) to help the pancreas safely handle and adapt to high-carbohydrate or high-starch foods. If these enzymes do not function properly, the body may struggle to produce the extra insulin it needs.

Drug Safety & Therapeutics

On-Label Use of Sodium-Glucose Cotransporter 2 Inhibitors Might Increase the Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes

Authors: Takeshi Horii, Yoichi Oikawa, Koichiro Atsuda, Akira Shimada

Research Objective: To investigate the real-world risk and timeline of diabetic ketoacidosis (DKA) in patients with Type 1 diabetes who are treated with SGLT2 inhibitors alongside insulin.

Methods: A retrospective, observational cohort study using a major Japanese clinical database. Out of 11,475 adult Type 1 diabetes patients, 1,898 were taking prescribed SGLT2 inhibitors. Incidence rates and hazard ratios of DKA were calculated using Cox multivariate regression.

Main Findings: Patients taking SGLT2 inhibitors experienced a significantly higher rate of DKA compared to non-users (7.3% vs. non-users; Hazard Ratio: 1.66). The average time to DKA onset was approximately 30.6 days after starting the drug, regardless of age, sex, or BMI. Interestingly, patients using continuous subcutaneous insulin pumps did not show an elevated risk, though the sample size was small.

Clinical Significance: Clinicians and Type 1 diabetes patients must be highly vigilant regarding DKA risks when initiating SGLT2 inhibitors, particularly during the critical first month of therapy.

Key Points for Patients: While SGLT2 inhibitors can offer benefits, if you have Type 1 diabetes, starting this medication carries an increased risk of a severe, life-threatening condition called diabetic ketoacidosis (DKA). This risk is highest during the first 30 days, making close monitoring and direct contact with your care team essential.

Complications & Nerve Regeneration

Painful Diabetic Neuropathy is Associated with Increased Nerve Regeneration in Patients with Type 2 Diabetes Undergoing Intensive Glycemic Control

Authors: Georgios Ponirakis, Muhammad A Abdul‐Ghani, Amin Jayyousi, Mahmoud A Zirie, Murtaza Qazi, Hamad Almuhannadi, Ioannis N Petropoulos, Adnan Khan, Hoda Gad, Osama Migahid, Ayman Megahed, Salma Al‐Mohannadi, Fatema AlMarri, Fatima Al‐Khayat, Ziyad Mahfoud, Hanadi Al Hamad, Marwan Ramadan, Ralph DeFronzo, Rayaz A Malik

Research Objective: To discover if the presence of painful diabetic nerve damage (neuropathy) impacts the physical regeneration of microscopic corneal (eye) nerves in Type 2 diabetes patients undergoing intensive blood sugar control.

Methods: An exploratory 1-year study evaluating participants with and without painful neuropathy using corneal confocal microscopy (to map small nerve fibers in the eye), skin conductance tests, and pain questionnaires. Patients received active therapies (exenatide + pioglitazone or intensive basal-bolus insulin).

Main Findings: Following intensive glycemic control and a significant drop in HbA1c, patients suffering from painful neuropathy showed a remarkable physical increase in corneal nerve fiber density, nerve length, and branching, alongside a notable decrease in their physical pain scores.

Clinical Significance: Active, rigorous blood sugar management doesn't just halt neuropathy; it actively facilitates small nerve fiber repair and yields real-world pain relief for patients.

Key Points for Patients: Committing to strict blood sugar control can actually help your body rebuild damaged small nerves. Over a year, this structural healing was shown to significantly reduce the daily, distressing pain caused by neuropathy.

Preventive Medicine & Care Retention

Association Between Nutritional Guidance or Ophthalmological Examination and Discontinuation of Physician Visits in Patients with Newly Diagnosed Diabetes: A Retrospective Cohort Study Using a Nationwide Database

Authors: Akira Okada, Sachiko Ono, Satoko Yamaguchi, Hayato Yamana, Kayo Ikeda Kurakawa, Nobuaki Michihata, Hiroki Matsui, Masaomi Nangaku, Toshimasa Yamauchi, Hideo Yasunaga, Takashi Kadowaki

Research Objective: To investigate if completing guideline-recommended care (such as nutritional counseling or professional eye exams) within the first month of a diabetes diagnosis prevents patients from dropping out of medical follow-ups.

Methods: A retrospective cohort study analyzing 6,508 newly diagnosed diabetes patients from a nationwide Japanese administrative database. Discontinuation of care was defined as going more than 6 months without a clinical visit.

Main Findings: Patients who underwent nutritional counseling or eye exams within their first month had a significantly lower medical dropout rate (17.2%) compared to those who did not receive these services (21.8%), demonstrating a 21% relative reduction in care abandonment.

Clinical Significance: Early engagement through multi-disciplinary care (nutritional support and preventative screening) is a powerful clinical strategy to keep new patients actively enrolled in long-term diabetes management.

Key Points for Patients: Getting a nutritional consultation or an eye exam right after being diagnosed with diabetes does more than protect your eyesight and diet; it helps you build a strong connection with your healthcare team and keeps you from falling out of the medical system.

Biomarkers & Screening

Association Between Serum Prostate-Specific Antigen Concentrations and the Risk of Developing Type 2 Diabetes Mellitus in Chinese Men: A Cohort Study

Authors: Shao‐fen Huang, Ying‐lin Yu, Yun‐feng Cui, Yan‐mei Lou, Min‐qi Liao, Chang‐yi Wang, Shan Xu, Hong‐en Chen, Xu‐ping Gao, Shu‐hong Dai, Xiao‐lin Peng, Dan Zhao, Li Wang, Zhao Ping, Fang‐fang Zeng

Research Objective: To explore the long-term relationship between blood levels of prostate-specific antigen (PSA) and the risk of developing Type 2 diabetes in men.

Methods: A cohort study following 16,811 non-diabetic Chinese men receiving annual health checkups over a median period of 3.8 years. Multi-variable analyses adjusted for age, weight, and other health variables.

Main Findings: Men with higher baseline levels of PSA in their blood had a significantly lower risk of developing Type 2 diabetes. This protective association was particularly prominent among men who were overweight or obese.

Clinical Significance: PSA levels could potentially serve as a biological marker to help doctors gauge and identify Type 2 diabetes risk in male patients.

Key Points for Patients: In men, especially those who struggle with weight, having a slightly higher (but normal) PSA level was associated with a lower chance of developing Type 2 diabetes. Future studies are working to understand the exact biological link behind this trend.

Heart & Nerve Complications

Insulin Resistance is Independently Associated with Cardiovascular Autonomic Neuropathy in Type 2 Diabetes

Authors: Yingshan Liu, Yu Peng, Jing Jin, Yanshan Chen, Chuna Chen, Zhenguo Chen, Haishan Huang, Lingling Xu

Research Objective: To investigate the relationship between insulin resistance severity (measured by HOMA2-IR based on C-peptide) and the development of diabetic cardiovascular autonomic neuropathy (DCAN), a dangerous form of nerve damage affecting the heart.

Methods: A clinical study of 109 patients with Type 2 diabetes. DCAN was diagnosed using Ewing tests (cardiovascular reflex tests). The HOMA2-IR index was used to precisely quantify insulin resistance.

Main Findings: Insulin resistance was significantly higher in patients with cardiovascular nerve damage and worsened as the damage progressed. Patients with a HOMA2-IR score greater than 1.735 were at a very high risk of DCAN, and this score proved to be a highly accurate diagnostic predictor.

Clinical Significance: Severe insulin resistance is a strong independent predictor of cardiac nerve damage, highlighting HOMA2-IR as a valuable, simple screening tool to identify high-risk patients before severe heart complications occur.

Key Points for Patients: When the body's cells resist insulin too strongly, it doesn't just raise blood sugar; it also places the nerves that control your heart rate and blood pressure at risk. A simple blood test calculation can tell your doctor if you are in the high-risk zone, allowing for early, protective treatments.